Search Results

Site Search

Severe storms affecting FedEx hub in Memphis, TN - Insights

Due to severe weather affecting the FedEx hub in Memphis, Tennessee, delays are anticipated. The Mayo Clinic Laboratories’ Global Logistics team will be diverting work to other commercial shipping options.  

Updated authentication for Mayo Clinic Laboratories - Insights

On Saturday, March 13 at 6 p.m. CT, Mayo Clinic Laboratories will be migrating to the authentication service used across Mayo Clinic.

Clinical microbiology at Mayo Clinic: A look back and ahead - Insights

The field of clinical microbiology has a long and distinguished history at Mayo Clinic. Since the early 1900s, the clinical microbiology team has played important and leading roles in advancing testing and patient care.

Why Measles Is on the Rise: Matthew Binnicker, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist...

Syphilis Testing Updates: Elitza Theel, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to...

Gastrointestinal Pathogen Panel, PCR, Feces [Test in Focus] - Insights

The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.

Mayo Clinic Laboratory and Pathology Research Roundup: March 19 - Insights

This week's research roundup feature: The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity with single lineage (MDS-RS-SLD) or...

Mayo Clinic Laboratory and Pathology Research Roundup: March 5 - Insights

This week's research roundup feature: Variants of uncertain significance (VUSs) in BRCA2 are a common result of hereditary cancer genetic testing. While more than 4,000 unique VUSs, comprised of missense or intronic variants, have been...

Mayo Clinic Laboratory and Pathology Research Roundup: March 12 - Insights

This week's research roundup feature: C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the alternative pathway of complement. C3G includes C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), both of which...

Mayo Clinic Laboratory and Pathology Research Roundup: March 27 - Insights

This week’s Research Roundup highlights pathogenic implications of distinct patterns of iron and zinc in chronic multiple sclerosis lesions.